Work

Randomized Phase II Study of Palifermin for Reducing Dysphagia in Patients Receiving Concurrent Chemoradiotherapy for Locally Advanced Unresectable Non-small Cell Lung Cancer

Year: 2011

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Journal of Thoracic Oncology

DOI: 10.1097/jto.0b013e31822f6526

Authors: Wolfgang Schuette, Maciej J. Krzakowski, Bartomeu Massuti, Gregory A. Otterson, Richard Lizambri, Helen Wei, Dietmar P. Berger, Yuhchyau Chen

Institutions: The Maria Sklodowska-Curie National Research Institute of Oncology, Hospital General Universitario de Alicante Doctor Balmis, The Ohio State University, Amgen (United States), University of Rochester Medicine, University of Rochester

Language: English

Topic: Lung Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Amgen, National Cancer Institute

Award: Cancer Center Support Grant

OpenAlex ID: W2036377912

FWCI: 1.296

Cites: 29

Cited by: 17

Related to: 10